1. Which of the following scoring systems can be used to assess atopic dermatitis disease severity via the assessment of both visual lesions AND subjective symptoms?

2. A key role of pharmacists in caring for patients with AD being prescribed TCSs is to address “corticophobia.” It is crucial for pharmacists to:

3. Which of the following available agents has the most robust data, including an FDA label for the treatment of moderate-to severe atopic dermatitis?

4. Which of the following agents has been historically associated with the development of malignancies?

5. Ariel is a 3-year old girl with a history of atopic dermatitis. She presents with her mom to your pharmacy with an acute flare. She currently uses an emollient and is not using any other medications. Which is the following is an appropriate recommendation for an acute flare of atopic dermatitis?

6. Jasmine is a 28-year-old that has been battling atopic dermatitis since childhood. Recently, her physician prescribed her topical calcineurin inhibitors to apply to newly affected areas on her face. She picked her up prescription 3 days ago and presents back to the pharmacy complaining of burning and tingling on her face. She says she's been compliant with the topical calcineurin inhibitor and asks you for advice. What do you recommend?

Evaluation Questions

7. How confident are you in your treatment recommendation above for Ariel?

8. How confident are you in your decision about treating adverse effects for your patient Jasmine above?

« Return to Activity